US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NYSE
Legacy Healthcare Properties (LRP)
Legacy Healthcare Properties (LRP) ニュース

LRP

Legacy Healthcare Properties (LRP)

Legacy Healthcare Properties

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:LRP

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2011/04/14	04 : 30	Edgar (US Regulatory)	Withdrawal of Registration Statement (RW)	NYSE:LRP	Legacy Healthcare Properties
2010/10/05	19 : 21	Edgar (US Regulatory)	Securities Registration: Real Estate Company (S-11/A)	NYSE:LRP	Legacy Healthcare Properties
2010/09/17	06 : 30	Edgar (US Regulatory)	Securities Registration: Real Estate Company (S-11/A)	NYSE:LRP	Legacy Healthcare Properties
2008/07/22	04 : 24	PR Newswire (US)	/C O R R E C T I O N from Source -- Lorus Therapeutics Inc./	NYSE:LRP
2008/07/21	20 : 30	PR Newswire (US)	Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008	NYSE:LRP
2008/07/16	21 : 12	PR Newswire (US)	Lorus Therapeutics Receives $600 Thousand From Escrow Account	NYSE:LRP
2008/07/09	21 : 00	PR Newswire (US)	Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development Program	NYSE:LRP
2008/07/02	22 : 00	PR Newswire (US)	Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with	NYSE:LRP
2008/06/23	20 : 30	PR Newswire (US)	Lorus Therapeutics announces that the European Medicines Agency (EMEA) has granted the orphan drug designation to LOR-2040 for t	NYSE:LRP
2008/05/07	05 : 22	PR Newswire (US)	AMEX Accepts Lorus' Plan to Meet AMEX's Continued Listing Standards	NYSE:LRP
2008/05/05	20 : 30	PR Newswire (US)	Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions	NYSE:LRP
2008/04/22	21 : 30	PR Newswire (US)	Lorus initiates development program exploring novel route of administration for LOR-2040	NYSE:LRP
2008/04/16	21 : 30	PR Newswire (US)	Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040	NYSE:LRP
2008/04/09	11 : 04	PR Newswire (US)	Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)	NYSE:LRP
2008/01/23	08 : 17	PR Newswire (US)	Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer	NYSE:LRP
2007/11/06	21 : 30	PR Newswire (US)	Lorus announces presentation of corporate overview at the Rodman and Renshaw Annual Healthcare Conference	NYSE:LRP
2007/09/20	11 : 23	PR Newswire (US)	Lorus Therapeutics announces election of three new Directors and appoints a new Chairman	NYSE:LRP
2007/08/29	21 : 30	PR Newswire (US)	Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia	NYSE:LRP
2007/07/24	07 : 48	PR Newswire (US)	Lorus Therapeutics Announces the Appointment of a New Member of the Board of Directors	NYSE:LRP
2007/07/11	09 : 04	PR Newswire (US)	Lorus Therapeutics completes reorganization resulting in non dilutive financing	NYSE:LRP
2007/07/06	06 : 39	PR Newswire (US)	Lorus Therapeutics announces revised closing date for proposed plan of arrangement	NYSE:LRP
2007/06/19	22 : 30	PR Newswire (US)	Lorus Therapeutics announces the initiation of a clinical trial of GTI-2040 in acute leukemia and myelodysplastic syndrome	NYSE:LRP
2007/05/14	22 : 30	PR Newswire (US)	Lorus announces presentation of corporate overview at the Acumen Biofin Rodman & Renshaw 4th Annual Global Healthcare Conference	NYSE:LRP
2007/05/02	11 : 59	PR Newswire (US)	Lorus Therapeutics announces reorganization resulting in approximately $7,800,000 of non-dilutive financing	NYSE:LRP
2007/04/19	22 : 30	PR Newswire (US)	Lorus Therapeutics reports third quarter results for fiscal year 2007	NYSE:LRP
2007/04/17	22 : 30	PR Newswire (US)	Lorus Therapeutics Announces Scientific Presentations for Lead Antisense and siRNA Drug Candidates at International Cancer Confe	NYSE:LRP
2007/03/01	22 : 00	PR Newswire (US)	Lorus Therapeutics Announces a Key Scientific Publication on Therapeutic siRNA in Cancer Therapy	NYSE:LRP
2006/12/29	21 : 00	PR Newswire (US)	Lorus Therapeutics reports second quarter results for fiscal year 2007	NYSE:LRP
2006/11/07	00 : 04	PR Newswire (US)	Lorus announces presentation of corporate overview at the Rodman and Renshaw 8th Annual Healthcare Conference	NYSE:LRP
2006/11/01	21 : 00	PR Newswire (US)	Lorus Therapeutics announces presentation on GTI-2040 uptake by tumor cells in acute myeloid leukemia	NYSE:LRP

Showing the most relevant articles for your search:NYSE:LRP

1 2 3 4 次へ >>

Boulder Growth and Income

Societe Generale Effekten

NLBNPIT21PH2 20241218 20...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約